Description

The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then as a yearly update to the voluminous encyclopedia, Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of adverse drug reactions and interactions. An international team of specialists has contributed to the informative Annual by critically interpreting it and by pointing to whatever is misleading.

Key Features

  • Provides a critical yearly survey of new data and trends
  • Special reviews in this Annual include, among other topics, epidemiology of the use of ecstasy, paracetamol and the risk of asthma, combination vaccines/multiple immunizations, interactions of herbal medicines with warfarin, and tyrosine kinase inhibitors

Readership

Pharmacologists, clinicians, pharmaceutical companies, clinical toxicologists, clinical pharmacologists and medical libraries

Table of Contents

Series Page

Contributors

Special reviews

Cumulative indexes of special reviews, Annuals 11–33

1. Index of drugs

2. Index of adverse reactions

Table of Essays, Annuals 1–33

Mechanistic and clinical descriptions of adverse drug reactions

1 EIDOS

2 DoTS

Definitive (between-the-eyes) adverse drug reactions

How to use this book

The scope of the Side Effects of Drugs Annuals

Period covered

Selection of material

Classification of drugs

Names of drugs and chemicals

System of tagging references

Indexes

Abbreviations

Side effects of drugs essay

An agenda for research into adverse drug reactions

Systematic reviews

Teleoanalysis

Conclusions

1. Central nervous system stimulants and drugs that suppress appetite

Amphetamines [SED-15, 180; SEDA-31, 1; SEDA-32, 1; SEDA-33, 1]

Methylxanthines

Drugs that suppress appetite [SEDA-30, 7; SEDA-31, 9; SEDA-32, 16; SEDA-33, 13]

Drugs used in Alzheimer’s disease [SEDA-31, 10; SEDA-32, 19; SEDA-33, 15]

References

2. Antidepressant drugs

General

Selective serotonin re-uptake inhibitors (SSRIs) [SED-15, 3109; SEDA-31, 18; SEDA-32, 33; SEDA-33, 26]

Serotonin and noradrenaline re-uptake inhibitors (SNRIs)

Tricyclic antidepressants

Other antidepressants

References

3. Lithium

References

4. Drugs of abuse

Cannabinoids [SED-15, 614; SEDA-31, 33; SEDA-32, 55; SEDA-33, 55]

Opioid analgesics

References

5. Hypnosedatives and anxiolytics

Azaspirones [SEDA-32, 75; SEDA-33, 71]

Benzodiazepines [SED-15, 429; SEDA-31, 57; SEDA-32, 75; SEDA-33, 71]

Benzodiazepine-like drugs

Benzodiazepine antagonists

Other hypnosedatives

References

6. Anti

Details

No. of pages:
904
Language:
English
Copyright:
© 2012
Published:
Imprint:
Elsevier
Electronic ISBN:
9780444595034
Print ISBN:
9780444594990

About the editor